US approval for Orthocell regeneration product

14/01/2021 - 15:00

Bookmark

Save articles for future reference.

Perth-based biotherapeutic company Orthocell has received US approval for the use of its dental bone and tissue regeneration platform.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options